Latest Bio-Amd Inc (BIAD) Headlines Bio-AMD,
Post# of 10
Bio-AMD, Inc. Patent Application for Immunoassay Result Reading Apparatus
PR Newswire - Fri Dec 28, 7:30AM CST
Bio-AMD, Inc. is pleased to announce that Bio AMD Limited, our majority owned medical devices subsidiary ("Bio-AMD", "We" or the "Company") (OTCBB: BIAD.OB), (OTCQB: BIAD) has submitted a UK Intellectual Property Office patent application for an Immunoassay Result Reading Apparatus ("IRRA").